• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine in the Mainland is expected to meet the needs of 5%

Pathfinder

Editor, Senior Moderator
Translation

A flow of the vaccine in the Mainland is expected to meet the needs of 5%

2009-8-22

【, Feb. 21, Chinese Health Minister Chen Zhu held in Beijing in response to influenza A H1N1 influenza and preparation for the international scientific symposium revealed that the mainland of China this year is expected by the end of Influenza A H1N1 influenza vaccine production to meet the needs of the population of 5%.

According to Xinhua News Agency, Beijing, August 21 -, Chen Zhu said that the influenza A H1N1 influenza prevention and control has achieved significant results, a comprehensive prevention and control measures significantly reduced the number of cases. Up to now, mainland China only found 1 case of severe cases, no deaths, there was no community-level outbreak. The epidemic did not cause a big impact on socio-economic development, social production and the normal order of public life, prevention and control work was supported by the public support and international recognition.

Chen Zhu said it had launched an urgent 10 seasonal influenza vaccine manufacturing enterprises to Influenza A H1N1 influenza vaccine research and development, the State Food and Drug Administration fast-track procedures for the implementation of the vaccine, the department concerned organizations to develop a clinical testing program. Currently, China has a certain capacity, by the end of 2009, is expected to meet 5% of corporate production needs of the population.

Chen Zhu, also introduced in response to the accumulation of influenza A H1N1 flu in six areas of experience. Including: the establishment of the response to influenza A H1N1 influenza joint prevention and control work mechanism; to adopt strict port entry-exit inspection and quarantine measures; strengthen the close contacts of management measures; to strengthen the monitoring and reporting; constantly adjust and improve the diagnosis and treatment of cases; to speed up vaccine research and development.

Chen Zhu said that despite the concerted efforts of countries under the previous phase the global prevention and control work has achieved initial results, but the current and future control efforts for some time will still face enormous challenges.

His initiative, countries do their disease prevention and control at the same time, should be to prevent the spread of the epidemic to fulfill obligations to the international community has given equal position; further strengthen the global influenza pandemic information exchange platform for system construction; further strengthen the vaccine and drug development R & D cooperation; support developing countries in pandemic influenza response capacity-building; States should work closely together, mutual respect for different national conditions and the coordination of epidemic prevention and control actions.

Influenza A H1N1 influenza response and preparation of international scientific symposium sponsored by the Chinese Ministry of Health, World Health Organization, "The Lancet" medical journal support for the Conference side. From 9 countries, Minister of Health, more than 30 countries and regions, more than 900 scientists on behalf of influenza prevention and control of the area participated in the seminar.


http://www.takungpao.com/news/09/08/22/zhuliugan01-1130685.htm
 
Back
Top